HNF4α-Mediated LINC02560 Promotes Papillary Thyroid Carcinoma Progression by Targeting the miR-505-5p/PDE4C Axis
Biomolecules · 2025
DOI: 10.3390/biom15050630 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Yongcheng Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine and Xiamen Key Laboratory for Tumor Metastasis, Cancer Research Center, School of Medicine, Xiamen Univers…. Hauptthemen laut MEDLINE: MicroRNAs, Thyroid Cancer, Papillary, RNA, Long Noncoding, Hepatocyte Nuclear Factor 4. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, National Natural Science Foundation of China, Scientific Research Foundation of Xiang An Biomedicine Laboratory.
Abstract (Originalsprache)
Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid malignancy, and its progression is closely associated with patient outcomes. This study investigated the role of the long non-coding RNA LINC02560 in the pathogenesis and aggressiveness of PTC through cell culture, transfection, RT-qPCR, Western blot analysis, and various functional assays, such as MTT, EdU, colony formation, wound healing, and Transwell migration assays. Our results revealed a significant upregulation of LINC02560 in PTC tissues, correlating with poor prognosis in affected patients. Functional analyses demonstrated that silencing of LINC02560 markedly inhibited the proliferation, migration, and invasion of the PTC cell lines, KTC-1, and BCPAP, whereas overexpression promoted these aggressive traits. Mechanistically, LINC02560 acted as a competitive endogenous RNA, sponging miR-505-5p and alleviating its suppression on PDE4C degradation, thereby activating the P-AKT and epithelial–mesenchymal transition (EMT) signaling pathways. Additionally, HNF4α was identified as a transcription factor capable of enhancing the expression of LINC02560. In conclusion, our findings elucidate the critical HNF4α/LINC02560/miR-505-5p/PDE4C axis in PTC pathology, presenting this regulatory network as a promising biomarker combination and potential therapeutic target to improve patient outcomes and survival rates, warranting further clinical investigation to validate these insights and support the development of targeted therapies in PTC management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine and Xiamen Key Laboratory for Tumor Metastasis, Cancer Research Center, School of Medicine, Xiamen University, Xiamen 361102, China.
- Department of Breast Surgery, The First Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China.
- Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
- Department of General Surgery, The First Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China.
- Shenzhen Research Institute of Xiamen University, Shenzhen 518057, China.
ORCID-Profile: Tianhui Hu
Förderung
- Shenzhen Science and Technology Program
- National Natural Science Foundation of China
- Scientific Research Foundation of Xiang An Biomedicine Laboratory
- Natural Science Foundation of Fujian Province of China
Zitieren
APA
Su, Y., Xu, B., Gao, C., Pei, W., Ma, M., Zhang, W., Hu, T., Zhang, F., & Zhang, S. (2025). HNF4α-Mediated LINC02560 Promotes Papillary Thyroid Carcinoma Progression by Targeting the miR-505-5p/PDE4C Axis. Biomolecules. https://doi.org/10.3390/biom15050630
Vancouver
Su Y, Xu B, Gao C, Pei W, Ma M, Zhang W, et al. HNF4α-Mediated LINC02560 Promotes Papillary Thyroid Carcinoma Progression by Targeting the miR-505-5p/PDE4C Axis. Biomolecules. 2025. doi:10.3390/biom15050630
BibTeX
@article{Su2025,
author = {Su, Yongcheng and Xu, Beibei and Gao, Chunyi and Pei, Wenbin and Ma, Miaomiao and Zhang, Wenqing and Hu, Tianhui and Zhang, Fuxing and Zhang, Shaoliang},
title = {HNF4α-Mediated LINC02560 Promotes Papillary Thyroid Carcinoma Progression by Targeting the miR-505-5p/PDE4C Axis},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15050630}
}
EUVIMED